Sutter Health Biobank 

The Sutter Health Biobank represents a comprehensive initiative to integrate genetic and genomic data with electronic health records. This advanced resource enables researchers to study healthy aging as well as the development and progression of disease. Insights gained from this work support the advancement of personalized medicine and the continual improvement of patient care

Help us pioneer the future of healthcare for our families and communities.

About the Biobank 

Patients who obtain care from Sutter Health are invited to donate blood samples and authorize access to medical data, which can then be used in research to accelerate medical discoveries and advance strategies to improve and maintain health. Learn more about the Biobank (PDF). As part of the Biobank, we are enrolling adults ages 35 through 90+. This cohort will contribute to research focused on healthy aging, chronic migraine, highly malignant forms of cancer, pre-clinical heart failure, multiple sclerosis, and movement disorders including Parkinson’s disease. People invited to participate can review detailed information in the Biobank consent form before deciding if they are interested.

The Biobank and the research using Biobank samples are approved by the Sutter Health Institutional Review Board. Learn more about the Sutter Health Institutional Review Board.

A message from Sutter Health’s Scientific Director:

Greetings to Sutter Health Biobank participants, collaborators, team, and community members! We have very exciting updates and major progress to report. First, I am excited to share our recent scientific publication, “Establishing a biospecimen repository of diverse populations in a network healthcare organization” published in Discover Health Systems. This publication describes the goals, design, and effort that went into creating the Sutter Health Biobank – and we couldn’t have done it without you! Please take a moment to have a look at your Sutter Health Biobank to learn more about the program.

Second, based on the samples collected as part of the Sutter Health Biobank, we have generated several large genomics datasets supporting numerous research programs. These studies include: whole genome genotyping data that allow us to examine clinically relevant genetic information about drug metabolism and disease risk; blood proteomic data that efficiently reveal insights into numerous clinical measures that normally require advanced imaging or biopsies to capture; and DNA methylation data that allow us to calculate biological age and determine how this is related to clinical outcomes. As always, personal health information of Biobank participants is protected and kept secure.

Third, in collaboration with Sutter Health physicians we are launching new studies in rheumatology and neurology. We are always eager to continue partnering with Sutter Health physicians in all specialties to develop new and innovative studies that will have meaningful impact on patient health.

In upcoming Sutter Health Biobank updates to this website we will showcase findings from the many genomics studies which are underway and update you on new studies as they launch.

Transformative research is only possible through the teamwork of patients, physicians, clinics and laboratories. We could not do this incredibly important work without you, and I am proud to be a part of this team.

Thank you for your participation, support and dedication!
Gregory Tranah, PhD

The Sutter Health Biobank reflects a unique collaboration among researchers, clinical leaders, healthcare providers, and patients to accelerate the discovery of new diagnostics and other interventions to address patient needs.

Researchers, are you interested in collaborating with the Sutter Health Biobank? Please send a message to BiobankAdmin@sutterhealth.org to discuss your project ideas.